01/02/2020
EvoFarma, the innovative EvoEnzyme´s project, has been granted with a CAM-RIS 3 for young innovative companies from the Community of Madrid and the European Regional development.
Grant co-funded by the European Regional Development Fund (ERDF/FEDER) under the 2019 call for the development of young innovative technology-based companies (Start-ups) and high innovation-intensity SMEs, within the framework of the regional strategy for Research and Innovation for Smart Specialisation (RIS3), under the ERDF/FEDER operational programme of the Community of Madrid. CAM RIS3 Line 1. Project No. S-2019/L1-274.